Inflammatory signals direct expression of human IL12RB1 into multiple distinct isoforms

Journal of Immunology

Volumn 189, Issue 9, 2012, Pages 4684-4694

  Ford, Nicole R ^a   Miller, Halli E ^a   Reeme, Allison E ^a   Waukau, Jill ^a   Bengtson, Christine ^a   Routes, John M ^a   Robinson, Richard T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 13; RNA;

ADULT; ARTICLE; CELL LINEAGE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA SPLICING; SIGNAL TRANSDUCTION;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 19; EXONS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HEK293 CELLS; HUMANS; INFLAMMATION MEDIATORS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-12; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION;

EID: 84867909487     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200606     Document Type: Article

References (87)

1. Szabo, S. J., B. M. Sullivan, S. L. Peng, and L. H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758. (Pubitemid 37174546)
2. Bennett, I. M., O. Zatsepina, L. Zamai, L. Azzoni, T. Mikheeva, and B. Perussia. 1996. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J. Exp. Med. 184: 1845-1856. (Pubitemid 26404475)
3. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429. (Pubitemid 38680428)
4. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748. (Pubitemid 36227625)
5. McGeachy, M. J., Y. Chen, C. M. Tato, A. Laurence, B. Joyce-Shaikh, W. M. Blumenschein, T. K. McClanahan, J. J. O'Shea, and D. J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10: 314-324.
6. Guia, S., C. Cognet, L. de Beaucoudrey, M. S. Tessmer, E. Jouanguy, C. Berger, O. Filipe-Santos, J. Feinberg, Y. Camcioglu, J. Levy, et al. 2008. A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 111: 5008-5016.
7. Bhardwaj, N., R. A. Seder, A. Reddy, and M. V. Feldman. 1996. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J. Clin. Invest. 98: 715-722. (Pubitemid 26349176)
8. Airoldi, I., G. Gri, J. D. Marshall, A. Corcione, P. Facchetti, R. Guglielmino, G. Trinchieri, and V. Pistoia. 2000. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J. Immunol. 165: 6880-6888. (Pubitemid 32001157)
9. Grohmann, U., M. L. Belladonna, R. Bianchi, C. Orabona, E. Ayroldi, M. C. Fioretti, and P. Puccetti. 1998. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 9: 315-323. (Pubitemid 28462752)
10. Chua, A. O., R. Chizzonite, B. B. Desai, T. P. Truitt, P. Nunes, L. J. Minetti, R. R. Warrier, D. H. Presky, J. F. Levine, M. K. Gately, and U. Gubler. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153: 128-136. (Pubitemid 24186525)
11. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
12. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C. Y. Wu, M. K. Gately, and U. Gubler. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93: 14002-14007.
13. Ehlayel, M., L. de Beaucoudrey, F. Fike, S. A. Nahas, J. Feinberg, J. L. Casanova, and R. A. Gatti. 2008. Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia. J. Allergy Clin. Immunol. 122: 1217-1219.
14. Luangwedchakarn, V., O. Jirapongsaranuruk, J. E. NiemeLa, C. Thepthai, K. Chokephaibulkit, S. Sukpanichnant, P. Pacharn, N. Visitsunthorn, P. Vichyanond, S. Piboonpocanun, and T. A. Fleisher. 2009. A novel mutation of the IL12RB1 gene in a child with nocardiosis, recurrent salmonellosis and neurofibromatosis type I: first case report from Thailand. Asian Pac. J. Allergy Immunol. 27: 161-165.
15. McGovern, D. P., J. I. Rotter, L. Mei, T. Haritunians, C. Landers, C. Derkowski, D. Dutridge, M. Dubinsky, A. Ippoliti, E. Vasiliauskas, et al. 2009. Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease. Inflamm. Bowel Dis. 15: 883-889.
16. Takahashi, N., M. Akahoshi, A. Matsuda, K. Ebe, N. Inomata, K. Obara, T. Hirota, K. Nakashima, M. Shimizu, M. Tamari, et al. 2005. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes. Hum. Mol. Genet. 14: 3149-3159. (Pubitemid 41631290)
17. Tanaka, G., I. Matsushita, J. Ohashi, N. Tsuchiya, S. Ikushima, M. Oritsu, M. Hijikata, T. Nagata, K. Yamamoto, K. Tokunaga, and N. Keicho. 2005. Evaluation of microsatellite markers in association studies: a search for an immune-related susceptibility gene in sarcoidosis. Immunogenetics 56: 861-870. (Pubitemid 40487422)
18. Akahoshi, M., H. Nakashima, K. Miyake, Y. Inoue, S. Shimizu, Y. Tanaka, K. Okada, T. Otsuka, and M. Harada. 2003. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum. Genet. 112: 237-243. (Pubitemid 36869080)
19. Altare, F., A. Durandy, D. Lammas, J. F. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Döffinger, F. Bernaudin, et al. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435. (Pubitemid 28264836)
20. de Beaucoudrey, L., A. Samarina, J. Bustamante, A. Cobat, S. Boisson-Dupuis, J. Feinberg, S. Al-Muhsen, L. Jannière, Y. Rose, M. de Suremain, et al. 2010. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89: 381-402.
21. Sanal, O., G. Turkkani, F. Gumruk, L. Yel, G. Secmeer, I. Tezcan, A. Kara, and F. Ersoy. 2007. A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis. Pediatr. Infect. Dis. J. 26: 366-368. (Pubitemid 46596670)
22. Tang, F., W. Liu, F. Zhang, Z. T. Xin, M. T. Wei, P. H. Zhang, H. Yang, H. Ly, and W. C. Cao. 2008. IL-12Rβ1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese. PLoS ONE 3: e2183.
23. Vinh, D. C., B. Schwartz, A. P. Hsu, D. J. Miranda, P. A. Valdez, D. Fink, K. P. Lau, D. Long-Priel, D. B. Kuhns, G. Uzel, et al. 2011. Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis. Clin. Infect. Dis. 52: e99-e102.
24. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254. (Pubitemid 23344886)
25. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155: 2515-2524.
26. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186: 39-45. (Pubitemid 27304845)
27. Papp, K. A., R. G. Langley, M. Lebwohl, G. G. Krueger, P. Szapary, N. Yeilding, C. Guzzo, M. C. Hsu, Y. Wang, S. Li, et al; PHOENIX 2 study investigators. 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371: 1675-1684. (Pubitemid 351671884)
28. Ding, C., J. Xu, and J. Li. 2008. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases. Curr. Opin. Investig. Drugs 9: 515-522. (Pubitemid 351677906)
29. Kimball, A. B., K. B. Gordon, R. G. Langley, A. Menter, R. J. Perdok, and J. Valdes; ABT-874 Study Investigators. 2011. Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial. J. Am. Acad. Dermatol. 64: 263-274.
30. Del Vecchio, M., E. Bajetta, S. Canova, M. T. Lotze, A. Wesa, G. Parmiani, and A. Anichini. 2007. Interleukin-12: biological properties and clinical application. Clin. Cancer Res. 13: 4677-4685. (Pubitemid 47294773)
31. Zou, J., D. H. Presky, C. Y. Wu, and U. Gubler. 1997. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J. Biol. Chem. 272: 6073-6077. (Pubitemid 27102449)
32. Parham, C., M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168: 5699-5708. (Pubitemid 34556153)
33. van de Vosse, E., R. A. de Paus, J. T. van Dissel, and T. H. Ottenhoff. 2005. Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency. Hum. Mol. Genet. 14: 3847-3855. (Pubitemid 43020086)
34. Levine, S. J. 2008. Molecular mechanisms of soluble cytokine receptor generation. J. Biol. Chem. 283: 14177-14181.
35. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472-475. (Pubitemid 23276556)
36. Hurst, S. M., T. S. Wilkinson, R. M. McLoughlin, S. Jones, S. Horiuchi, N. Yamamoto, S. Rose-John, G. M. Fuller, N. Topley, and S. A. Jones. 2001. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14: 705-714. (Pubitemid 32592418)
37. Robinson, R. T., S. A. Khader, C. A. Martino, J. J. Fountain, M. Teixeira-Coelho, J. E. Pearl, S. T. Smiley, G.M.Winslow, D. L.Woodland, M. J.Walter, et al. 2010. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J. Exp. Med. 207: 591-605.
38. Fuss, I. J., M. E. Kanof, P. D. Smith, and H. Zola. 2009. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr. Protoc. Immunol. Chapter 7: Unit7 1.
39. O'Flynn, K., M. Russul-Saib, I. Ando, D. L. Wallace, P. C. Beverley, A. W. Boylston, and D. C. Linch. 1986. Different pathways of human T-cell activation revealed by PHA-P and PHA-M. Immunology 57: 55-60. (Pubitemid 16232217)
40. Chambers, I., D. Colby, M. Robertson, J. Nichols, S. Lee, S. Tweedie, and A. Smith. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655. (Pubitemid 36694189)
41. Barreau, C., L. Paillard, and H. B. Osborne. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33: 7138-7150. (Pubitemid 43125082)
42. van de Vosse, E., E. G. Lichtenauer-Kaligis, J. T. van Dissel, and T. H. Ottenhoff. 2003. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 54: 817-829.
43. Rost, S., A. Fregin, V. Ivaskevicius, E. Conzelmann, K. Hörtnagel, H. J. Pelz, K. Lappegard, E. Seifried, I. Scharrer, E. G. Tuddenham, et al. 2004. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427: 537-541. (Pubitemid 38209110)
44. O'Callaghan, K. M., V. Ayllon, J. O'Keeffe, Y. Wang, O. T. Cox, G. Loughran, M. Forgac, and R. O'Connor. 2010. Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking. J. Biol. Chem. 285: 381-391.
45. Morris, D. P., R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn. 2004. Cellular trafficking of human alpha1a-adrenergic receptors is continuous and primarily agonist-independent. Mol. Pharmacol. 66: 843-854. (Pubitemid 39319456)
46. Laufman, O., W. Hong, and S. Lev. 2011. The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport. J. Cell Biol. 194: 459-472.
47. Subramaniam, V. N., E. Loh, H. Horstmann, A. Habermann, Y. Xu, J. Coe, G. Griffiths, and W. Hong. 2000. Preferential association of syntaxin 8 with the early endosome. J. Cell Sci. 113: 997-1008. (Pubitemid 30179479)
48. Seibel, N. M., J. Eljouni, M. M. Nalaskowski, and W. Hampe. 2007. Nuclear localization of enhanced green fluorescent protein homomultimers. Anal. Biochem. 368: 95-99. (Pubitemid 47058434)
49. Agostini, C., and G. Semenzato. 2003. Sarcoidosis. In Granulomatous Infections and Inflammations: Celular and Molecular Mechanisms. D. L. Boros, ed. ASM Press, Washington, DC, p. 265-292.
50. de Beaucoudrey, L., A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Jannière, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205: 1543-1550. (Pubitemid 351962017)
51. Sakai, T., M. Matsuoka, M. Aoki, K. Nosaka, and H. Mitsuya. 2001. Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 97: 2688-2694.
52. Cárdenes, M., A. Angel-Moreno, C. Fieschi, I. Sologuren, E. Colino, A. Molinés, M. I. García-Laorden, M. I. Campos-Herrero, M. Andújar-Sánchez, J. L. Casanova, and C. Rodríguez-Gallego. 2010. Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency. J. Med. Genet. 47: 635-637.
53. Moraes-Vasconcelos, D., A. S. Grumach, A. Yamaguti, M. E. Andrade, C. Fieschi, L. de Beaucoudrey, J. L. Casanova, and A. J. Duarte. 2005. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin. Infect. Dis. 41: e31-e37.
54. Sahiratmadja, E., R. Baak-Pablo, A. W. de Visser, B. Alisjahbana, I. Adnan, R. van Crevel, S. Marzuki, J. T. van Dissel, T. H. Ottenhoff, and E. van de Vosse. 2007. Association of polymorphisms in IL-12/IFN-gamma pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis (Edinb.) 87: 303-311. (Pubitemid 46936242)
55. Kusuhara, K., K. Yamamoto, K. Okada, Y. Mizuno, and T. Hara. 2007. Association of IL12RB1 polymorphisms with susceptibility to and severity of tuberculosis in Japanese: a gene-based association analysis of 21 candidate genes. Int. J. Immunogenet. 34: 35-44. (Pubitemid 46232340)
56. Remus, N., J. El Baghdadi, C. Fieschi, J. Feinberg, T. Quintin, M. Chentoufi, E. Schurr, A. Benslimane, J. L. Casanova, and L. Abel. 2004. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. J. Infect. Dis. 190: 580-587. (Pubitemid 38982099)
57. Lan, Q., S. S. Wang, I. Menashe, B. Armstrong, Y. Zhang, P. Hartge, M. P. Purdue, T. R. Holford, L. M. Morton, A. Kricker, et al. 2011. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies. Br. J. Haematol. 153: 341-350.
58. Hong, X., G. Wang, X. Liu, R. Kumar, H. J. Tsai, L. Arguelles, K. Hao, C. Pearson, K. Ortiz, A. Bonzagni, et al. 2011. Gene polymorphisms, breastfeeding, and development of food sensitization in early childhood. J. Allergy Clin. Immunol. 128:374-381.e2.
59. Zhang, L., D. Prather, J. Vanden Eng, S. Crawford, S. Kariuki, F. ter Kuile, D. Terlouw, B. Nahlen, A. A. Lal, L. Slutsker, et al. 2010. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya. Malar. J. 9: 87.
60. Russell, T. D., Q. Yan, G. Fan, A. P. Khalifah, D. K. Bishop, S. L. Brody, and M. J. Walter. 2003. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J. Immunol. 171: 6866-6874. (Pubitemid 37532122)
61. Canda-Sánchez, A., F. J. Salgado, A. Pérez-Díaz, C. Varela-González, P. Arias, and M. Nogueira. 2009. Differential distribution of both IL-12Rbeta chains in the plasma membrane of human T cells. J. Membr. Biol. 227: 1-12.
62. Presky, D. H., L. J. Minetti, S. Gillessen, V. L. Wilkinson, C. Y. Wu, U. Gubler, R. Chizzonite, and M. K. Gately. 1998. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J. Immunol. 160: 2174-2179. (Pubitemid 28119896)
63. Karaghiosoff, M., H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, et al. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13: 549-560.
64. Rathore, S. S., E. G. Bend, H. Yu, M. Hammarlund, E. M. Jorgensen, and J. Shen. 2010. Syntaxin N-terminal peptide motif is an initiation factor for the assembly of the SNARE-Sec1/Munc18 membrane fusion complex. Proc. Natl. Acad. Sci. USA 107: 22399-22406.
65. Südhof, T. C., and J. E. Rothman. 2009. Membrane fusion: grappling with SNARE and SM proteins. Science 323: 474-477.
66. Verhage, M., A. S. Maia, J. J. Plomp, A. B. Brussaard, J. H. Heeroma, H. Vermeer, R. F. Toonen, R. E. Hammer, T. K. van den Berg, M. Missler, et al. 2000. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287: 864-869. (Pubitemid 30084331)
67. Durali, D., M. G. de Goër de Herve, J. Giron-Michel, B. Azzarone, J. F. Delfraissy, and Y. Taoufik. 2003. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 102: 4084-4089.
68. Lynch, K. W. 2004. Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 4: 931-940. (Pubitemid 39620068)
69. König, H., H. Ponta, and P. Herrlich. 1998. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 17: 2904-2913.
70. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3: 764-771.
71. Heyd, F., and K. W. Lynch. 2010. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol. Cell 40: 126-137.
72. Arhin, G. K., M. Boots, P. S. Bagga, C. Milcarek, and J. Wilusz. 2002. Downstream sequence elements with different affinities for the hnRNP H/H' protein influence the processing efficiency of mammalian polyadenylation signals. Nucleic Acids Res. 30: 1842-1850. (Pubitemid 34679763)
73. Bagga, P. S., G. K. Arhin, and J. Wilusz. 1998. DSEF-1 is a member of the hnRNP H family of RNA-binding proteins and stimulates pre-mRNA cleavage and polyadenylation in vitro. Nucleic Acids Res. 26: 5343-5350. (Pubitemid 28542733)
74. Decorsière, A., A. Cayrel, S. Vagner, and S. Millevoi. 2011. Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 premRNA 3′-end processing and function during DNA damage. Genes Dev. 25: 220-225.
75. Li, T., E. Evdokimov, R. F. Shen, C. C. Chao, E. Tekle, T. Wang, E. R. Stadtman, D. C. Yang, and P. B. Chock. 2004. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl. Acad. Sci. USA 101: 8551-8556. (Pubitemid 38745808)
76. Liu, Q., and G. Dreyfuss. 1995. In vivo and in vitro arginine methylation of RNA-binding proteins. Mol. Cell. Biol. 15: 2800-2808.
77. Matunis, M. J., J. Xing, and G. Dreyfuss. 1994. The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res. 22: 1059-1067. (Pubitemid 24162170)
78. Rush, J., A. Moritz, K. A. Lee, A. Guo, V. L. Goss, E. J. Spek, H. Zhang, X. M. Zha, R. D. Polakiewicz, and M. J. Comb. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23: 94-101. (Pubitemid 41724631)
79. Millevoi, S., and S. Vagner. 2010. Molecular mechanisms of eukaryotic premRNA 39 end processing regulation. Nucleic Acids Res. 38: 2757-2774.
80. Musikacharoen, T., A. Oguma, Y. Yoshikai, N. Chiba, A. Masuda, and T. Matsuguchi. 2005. Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling. Blood 105: 711-720. (Pubitemid 40070757)
81. Lou, H., G. J. Cote, and R. F. Gagel. 1994. The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing. Mol. Endocrinol. 8: 1618-1626.
82. Lou, H., and R. F. Gagel. 1998. Alternative RNA processing - its role in regulating expression of calcitonin/calcitonin gene-related peptide. J. Endocrinol. 156: 401-405. (Pubitemid 28131456)
83. Lynch, K. W., and A. Weiss. 2001. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276: 24341-24347.
84. Motta-Mena, L. B., S. A. Smith, M. J. Mallory, J. Jackson, J. Wang, and K. W. Lynch. 2011. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs). J. Biol. Chem. 286: 20043- 20053.
85. Kerkar, S. P., R. S. Goldszmid, P. Muranski, D. Chinnasamy, Z. Yu, R. N. Reger, A. J. Leonardi, R. A. Morgan, E. Wang, F. M. Marincola, et al. 2011. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors. J. Clin. Invest. 121: 4746-4757.
86. Segal, B. M., C. S. Constantinescu, A. Raychaudhuri, L. Kim, R. Fidelus-Gort, and L. H. Kasper; Ustekinumab MS Investigators. 2008. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 7: 796-804.
87. Metzger, D. W. 2010. Interleukin-12 as an adjuvant for induction of protective antibody responses. Cytokine 52: 102-107.